Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0015 | 1 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.00096 | 1 |
mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.00095 | 1 |
mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.00073 | 1 |
mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.0025 | 1 |
mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.00066 | 1 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |